Autism spectrum disorder (ASD) etiology is a complex mixture of genetic and 15 environmental factors, the relative contributions of which varies across patients. Despite 16 complex etiology, researchers observe consistent neurodevelopmental features in ASD 17 patients, notably atypical forebrain cortical development. Growth factors, cytokines, and 18 chemokines are important mediators of forebrain cortical development, but have not been 19 thoroughly examined in brain tissues from individuals with autism. Here, we performed an 20 integrative analysis of RNA and protein expression using frontopolar cortex tissues dissected 21 from individuals with ASD and controls, hypothesizing that ASD patients will exhibit aberrant 22 expression of growth factors, cytokines, and chemokines critical for neurodevelopment. We 23 performed group-wise comparisons of RNA expression via RNA-Seq and growth factor, 24
Introduction

38
Autism spectrum disorders (ASD) constitute a variety of neurodevelopmental disorders 39 defined clinically by difficulties in socialization, restricted or repetitive behaviors, and language 40 delays, with childhood onset. ASD can be accompanied by concomitant symptoms including 41 intellectual disability, catatonia, seizures, attention deficit hyperactivity disorder, and 42 gastrointestinal dysfunction [1] . The cause of ASD is complex and involves both genetic and 43 environmental risk factors.
44
The diagnostic clinical signs of ASD are preceded by many other phenotypic changes,
45
including abnormal brain overgrowth in multiple brain regions. The frontal cortex, which is 46 involved in higher-order social, emotional, communicative, and cognitive functions is implicated amongst these overgrowth regions [2,3] and exhibits abnormal laminar structure [4] .
48
Functionally, the anterior frontal cortex (frontopolar cortex; Brodmann Area 10 -BA10) in 49 individuals with ASD exhibits altered interhemispheric connectivity, which correlates with social 50 deficits [5] . Others have found changes in temporal dynamics of resting state activity between 51 the frontopolar cortex and other brain regions that correlate with attention deficits in ASD [6] .
52
The abundance of evidence implicating the frontal cortex in ASD forms the basis of a unifying 53 theory of ASD etiology [7] , making this brain region an important focus for molecular and genetic 54 analysis.
55
Genetic studies have started to unravel the molecular basis of autism. Genome wide 56 associations [8] and whole-exome sequencing [9-11] reveal hundreds of rare and common 57 inherited and de novo variants that contribute to autism risk. These variants often implicate 58 processes related to neurodevelopment and neuronal function [8, [12] [13] [14] . Neuroglial are critical 59 for typical neural and synaptic development and modulating neuroinflammation, placing them 60 central to the notable dysfunctions in ASD [15] . Genomic studies show that glial cell-mediated 61 neuroinflammation is upregulated in the brains of individuals with ASD [16] [17] [18] . With respect to 62 the frontal cortex, epigenetic changes in ASD occur adjacent to genes responsible for immune functions and synaptic maturation [19, 20] . Increased pro-inflammatory factors are also found in 64 peripheral blood [21, 22] and brains from ASD patients [23] . Given 
77
Given the apparent associations between cytokine and chemokine signaling, 78 neurodevelopment, and ASD, our overall aim is to clarify the interactions between these factors 79 using a comprehensive genomic approach in frontopolar cortex brain tissues from individuals 80 with ASD and matched controls. Analysis of multiple chemokines and cytokines, whole 81 transcriptome RNA-Seq profiling, and single nuclear RNA-Seq reveals convergent evidence that 82 VEGF-A is upregulated in the cortex of ASD subjects, likely contributing to neuroinflammation.
83
Materials and Methods
84
Samples & RNA Isolation
85
Brain tissues were obtained through the Autism Tissue Program. They were dissected 86 postmortem from the frontopolar cortex (BA10) of individuals with ASD (n=17) and controls 87 (n=14). Subjects were predominately male (26M: 5F), white (28 white, 3 African-American), and 88 ranged in age from 2-57 years old. We isolated RNA from these tissues using TRIzol 
139
According to the manufacturer's instructions, we thawed homogenates at room temperature, 140 diluted 1μg of total protein 1:5 with PBS, and incubated in the plate for 12 h at 4 °C. We we performed standard Western blot analyses, normalizing our proteins of interest to β-actin.
151
We purchased the anti-PSD-95 (catalog #: D27E11) and anti-Actin (catalog #: 13E5) antibodies Comparing ASD cases to typically developed controls for our RNA-Seq data, we 185 observed 11 genes that were significantly upregulated in ASD cases (Figure 1 ). Amongst them 186 was VEGFA, encoding the VEGF-A protein, exhibiting approximately a 2-fold increase in ASD 187 frontopolar cortex. We performed qPCR analysis on a subset of genes in the samples with 188 acceptable RNA quality to confirm our RNA-Seq findings. Five of 6 genes we tested with qPCR 189 exhibited higher expression in ASD than controls, consistent with our RNA-Seq findings ( Figure   190 2). Two of the genes trended toward significant differences between cases and controls 191 (VEGFA, p = 0.058 and ADGRG1, p = 0.072). When comparing expression measured by RNA-
192
Seq and qPCR for VEGFA, we observed significant negative correlation between normalized 193 kallisto gene abundance estimates and ACTB-normalized C T values (r=-0.62, p=0.024), as 194 would be expected, since lower C T values in this analysis represent higher gene expression.
195
The VEGFA qPCR primers targeted the exon 2-3 junction, which we found to be more abundant 196 in ASD samples than controls in our RNA-Seq experiment ( Supplemental Table S2 ). Thus, our Figure S1 , Supplemental Table S2 ), which include exon 8a -the higher affinity form for NRP-1 222 binding. We did not find any evidence for usage of alternative exon 8b, associated with reduced 223 neuropilin-1 receptor (NRP-1) affinity [42] . We tested whether any specific isoform was 224 responsible for the increased VEGFA expression in ASD by examining differential exon 225 expression transcriptome-wide using DEXSeq. With respect to VEGFA, this analysis revealed 226 nominally significant increases in exons 1 and 6a and a nominally significant decrease in exon 8
227
( Table 2 , Supplemental Figure S2 ). We also found differentially expressed exons from eight 228 other genes that reached transcriptome-wide significance ( Table 2) . VEGFA exons 1 and 8 are 229 constitutive exons for VEGF-A 121 , VEGF-A 165 , and VEGF-A 189 , but exon 6a is only included in VEGF-A 189 . Therefore, we find it plausible that the isoform encoding VEGF-A 189 is responsible 231 for increased VEGFA RNA expression in ASD. Table S3 ). Of 240 the 21 analyzed proteins, IL-1β, RANTES (CCL5), and VEGF-A was significantly increased in 241 the brains of ASD cases versus controls (Figure 3 ), while GRO (CXCL1), IL-6, and MIP-1α 242 (CCL3) trended towards significant increases ( Supplemental Table S3 ). Here, we note that 243 capping the outliers in our protein analyses resulted in tighter distribution of values, especially 244 across the ASD samples, affecting the significance of the results ( Supplemental Table S3 ).
232
245
However, the outlier capping did not affect the direction of effects or our interpretation of the 246 data, as the outliers were exclusively ASD samples with greatly increased cytokine and chemokine levels. On average, the ASD cohort expressed approximately 1. 
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Our WGCNA analysis identified 15 unique co-expression networks. Of particular note, 267 the network eigengene most highly correlated with VEGF-A protein expression (r=0.65, p=1x10 -268 4 , arbitrarily named the "green" network; 435 total genes; see Supplemental Table S4 for all 269 gene clusters) is also significantly correlated with 11 additional cytokines and chemokines,
270
including IL-1β (Supplemental Figure S3 ). Consequently, we focused on the "green" network for 271 pathway analysis using IPA. We performed a Core Analysis using the 435 "green" network 272 genes, revealing multiple lines of evidence that suggests this co-expression network is related to pro-inflammatory signaling. Specifically, the top "Upstream Regulators" are 274 lipopolysaccharide and TNF, the top "Disease and Disorder" annotation is "inflammatory 275 response", and the top "Physiological System Development and Function" annotation is 276 "immune cell trafficking" (Supplemental Table S5 ). The Activation Z-scores generated by the 277 gene expression fold-changes consistently finds that the ASD cohort gene expression is 278 associated with greater immune and inflammatory pathways and functions. Additionally, "vegf",
279
"VEGFA", "IL1B", and "CCL5" are all predicted to be significant upstream activators of the 280 "green" gene network ( Supplemental Table S5 ), bolstering the association we observed (Figure 4 and Supplemental Table S6 ). Following clustering, we examined the 289 enrichment of VEGFA and groups of genes, including differentially expressed RNA-Seq genes 290 and those genes included in the "green" WGCNA network, across the different cell types.
291
VEGFA was most strongly expressed in oligodendrocyte progenitor cells (OPCs) and astrocytes 292 (Figure 5a, 5b) . The group of 11 differentially expressed RNA-Seq genes are enriched in non-293 neuronal cell populations, including astrocytes, oligodendrocytes, microglia, and OPCs ( Figure   294 6a), while genes from the "green" network are enriched specifically in microglia (Figure 6b ).
Fig 4. t-SNE Plot of Cell Type Clusters from Single Cell RNA-Seq in Frontopolar
296 Cortex
297
We clustered 13 different cell types from the frontopolar cortex of typically developed 298 individuals using publicly available data from [38] . The cell type markers we identified are consistent with the markers from the original manuscript (see Supplemental Table S6 ).
300
Abbreviations: OPCs = oligodendrocyte progenitor cells. 
316
Although our WGCNA and single-cell analyses find that VEGF-A expression is 317 significantly correlated with groups of genes that are strongly associated with neuroinflammation 318 and enriched in microglia, we cannot discern a cause-and-effect relationship from our analyses.
319
Activated microglia in ASD could stimulate the release of VEGF-A, resulting in a breakdown of 320 the local microvasculature and subsequent inflammation and angiogenesis. Alternatively,
321
increased VEGF-A could be a protective anti-inflammatory response to tonic neuroinflammation 322 observed in ASD. Arguing against a neuroprotective role, the isoform of VEGF-A typically 323 associated with anti-inflammatory response encodes exon 8b [45, 46] , which we do not see in 324 our splicing analysis.
Conclusions: Cytokines & VEGF-A in the Context of ASD & Neurodevelopment
326
Our analyses of RNA and protein expression revealed converging evidence that VEGF-
327
A is increased in the frontal cortex of individuals with ASD, with concurrent increases in the pro-328 inflammatory cytokines IL-1β and RANTES. Interpreting this finding and understanding its 329 significance requires us to consider the regulation of VEGF-A expression and the many roles 330 VEGF-A plays in normal and aberrant neurodevelopment and ongoing brain-related processes.
331
This includes the diametric roles VEGF-A can play in angiogenesis, neuroinflammation, and 332 neurodevelopment, which depend on VEGF-A isoform expression and the complement of VEGF 333 receptors through which the ligand is signaling. We also must consider peripheral levels of 334 VEGF-A versus those observed in the central nervous system, as changes in VEGF-A and its 335 receptors have been detected in the periphery of ASD patients.
336
Increased IL-1β and RANTES is observed in peripheral blood from ASD patients [47] . 
378
Few studies currently link VEGF-A dysregulation to ASD, perhaps owing the lack of 379 published studies that have examined this growth factor in ASD brain tissues or etiologic 380 heterogeneity across ASD patient populations. Given this caveat, we cautiously interpret our 381 findings and encourage replication studies and those that examine VEGF-A levels in the brains 
